Glial-derived proteins activate cultured astrocytes and enhance beta amyloid-induced glial activation

Brain Research

Volumn 842, Issue 1, 1999, Pages 46-54

  Hu, Jingru ^a   Van Eldik, Linda J ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Antichymotrypsin; Butyrylcholinesterase; Interleukin 1; Nitric oxide synthase; S100

Indexed keywords

AMYLOID BETA PROTEIN; INTERLEUKIN 1BETA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; GLIA CELL; NEUROFIBRILLARY TANGLE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; RAT;

ALPHA 1-ANTICHYMOTRYPSIN; AMYLOID BETA-PROTEIN; ANIMALS; ASTROCYTES; BLOTTING, WESTERN; BUTYRYLCHOLINESTERASE; CELL AGGREGATION; CELLS, CULTURED; INTERLEUKIN-1; MACROPHAGE ACTIVATION; NERVE TISSUE PROTEINS; NEUROGLIA; NITRATES; RATS; S100 PROTEINS;

EID: 0033581352     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01804-1     Document Type: Article

References (55)

1. Akama K.T., Albanese C., Pestell R.G., Van Eldik L.J. Amyloid β-peptide stimulates nitric oxide production in astrocytes through an NFκB-dependent mechanism. Proc. Natl. Acad. Sci. USA. 95:1998;5795-5800.
2. Bales K.R., Du Y., Dodel R.C., Yan G.M., Hamilton-Byrd E., Paul S.M. The NFκB/Rel family of proteins mediates Aβ-induced neurotoxicity and glial activation. Mol. Brain Res. 57:1998;63-72.
3. Benveniste E.N. Inflammatory cytokines within the central nervous system: source, function, and mechanism of action. Am. J. Physiol.: Cell Physiol. 32:1992;C1-C16.
4. Boland K., Manias K., Perlmutter D.H. Specificity in recognition of amyloid-beta peptide by the serpin-enzyme complex receptor in hepatoma and neuronal cells. J. Biol. Chem. 270:1995;28022-28028.
5. Boland K., Behrens M., Choi D., Manias K., Perlmutter D.H. The serpin-enzyme complex receptor recognizes soluble nontoxic amyloid-β peptide but not aggregated, cytotoxic amyloid-β peptide. J. Biol. Chem. 271:1996;18032-18044.
6. Buxbaum J.D., Oishi M., Chen H.I., Pinkas-Kramarski R., Jaffe E.A., Gandy S.E., Greengard P. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. USA. 89:1992;10075-10078.
7. Chao C.C., Hu S., Sheng W.S., Bu D.M., Bukrinsky M.I., Peterson P.K. Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia. 16:1996;276-284.
8. Chao C.C., Hu S., Peterson P.K. β-Amyloid protein-induced microglial cell activation. Alzheimers Disease Review. 3:1998;87-90.
9. Choi C., Park J.Y., Lee J., Lim J.H., Shin E.C., Ahn Y.S., Kim C.H., Kim S.J., Kim J.D., Choi I.S., Choi I.H. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-α, or IFN-γ J. Immunol. 162:1999;1889-1895.
10. Crawford F., Fallin D., Suo Z., Abdullah L., Gold M., Gauntlett A., Duara R., Mullan M. The butyrylcholinesterase is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations. Neurosci. Lett. 249:1998;115-118.
11. Das S., Potter H. Expression of Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1. Neuron. 14:1995;447-456.
12. Eddleston M., Mucke L. Molecular profile of reactive astrocytes-implications for their role in neurologic disease. Neuroscience. 54:1993;15-36.
13. El Khoury J., Hickman S.E., Thomas C.A., Cao L., Silverstein S.C., Lolke J.D. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature. 382:1996;716-719.
14. Eriksson S., Janciauskiene S., Lannfelt L. α1-antichymotrypsin regulates Alzheimer's β-amyloid peptide fibril formation. Proc. Natl. Acad. Sci. USA. 92:1995;2313-2317.
15. Forloni G., Demicheli F., Giorgi S., Bendotti C., Angeretti N. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. Mol. Brain Res. 16:1992;128-134.
16. Fraser P.E., Nguyen J.T., McLachlan D.R., Abraham C.R., Kirschner D.A. α1-antichymotrypsin binding to Alzheimer Aβ peptides is sequence specific and induces fibril disaggregation in vitro. J. Neurochem. 61:1993;298-305.
17. Gomez-Ramos P., Moran M.A. Ultrastructural localization of butylrylcholinesterase in the brain of aged and Alzheimer disease patients. Mol. Chem. Neuropathol. 30:1997;161-173.
18. Griffin W.S., Sheng J.G., Royston M.C., Gentleman S.M., McKenzie J.E., Graham D.I., Roberts G.W., Mrak R.E. Glial-neuronal interactions in Alzheimer's disease: the potential role of a cytokine cycle in disease progression. Brain Pathol. 8:1998;65-72.
19. Grilli M., Goffi F., Memo M., Spano P. Interleukin-1beta and glutamate activate the NF-kappaB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J. Biol. Chem. 271:1996;15002-15007.
20. Guillozet A.L., Smiley J.F., Mash D.C., Mesulam M.M. Butylrylcholinesterase in the life cycle of amyloid plaques. Ann. Neurol. 42:1997;909-918.
21. Hiltunen M., Mannermaa A., Helisalmi S., Koivisto A., Lehtovirta M., Ryynanen M., Riekkinen Sr P., Soininen H. Butyrylcholinesterase K variant and apolipoproteins E4 genes do not act in synergy in Finnish late-onset Alzheimers's disease patients. Neurosci. Lett. 250:1998;69-71.
22. Hsu H.C., Zhou T., Yang P.A., Herrera G.A., Mountz J.D. Increased acute-phase response and renal amyloidosis in aged CD2-fas-transgenic mice. J. Immunol. 158:1997;5988-5996.
23. Hu J., Van Eldik L.J. S100β induces apoptotic cell death in cultured astrocytes via a nitric oxide-dependent pathway. Biochim. Biophys. Acta. 1313:1996;239-245.
24. Hu J., Castets F., Guevara J.L., Van Eldik L.J. S100β stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes. J. Biol. Chem. 271:1996;2543-2547.
25. Hu J., Ferreira A., Van Eldik L.J. S100β induces neuronal cell death through nitric oxide release from astrocytes. J. Neurochem. 69:1997;2294-2301.
26. Hu J., Akama K.T., Krafft G.A., Chromy B.A., Van Eldik L.J. Amyloid-β peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release. Brain Res. 785:1998;195-206.
27. Hu J., Ladu M.J., Van Eldik L.J. Apolipoprotein E attenuates β-amyloid-induced astrocyte activation. J. Neurochem. 71:1998;1626-1634.
28. Janciauskiene S., Eriksson S., Wright H.T. A specific structural interaction of Alzheimer's peptide Aβ1-42 with α1-antichymotrypsin. Nat. Struct. Biol. 3:1996;668-671.
29. Janciauskiene S., Rubin H., Lukacs C.M., Wright H.T. Alzheimer's peptide Aβ1-42 binds to two β-sheets of α1-antichymotrypsin and transforms it from inhibitor to substrate. J. Biol. Chem. 273:1998;28360-28364.
30. Kalsheker N.A. α1-Antichymotrypsin. Int. J. Biochem. Cell Biol. 28:1996;961-964.
31. Lee S.J., Hou J., Benveniste E.N. Transcriptional regulation of intercellular adhesion molecule-1 in astrocytes involves NF-kappaB and C/EBP isoforms. J. Neuroimmunol. 92:1998;196-207.
32. Lehmann D.J., Johnston C., Smith A.D. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. Hum. Mol. Genet. 6:1997;1933-1936.
33. Lieb K., Fiebich B.L., Schaller H., Berger M., Bauer J. Interleukin-1 beta and tumor necrosis factor-alpha induce expression of alpha1-antichymotrypsin in human astrocytoma cells by activation of nuclear factor-kappa B. J. Neurochem. 67:1996;2039-2044.
34. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
35. Ma J., Yee A., Brewer Jr B., Das S., Potter H. Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature. 372:1994;92-94.
36. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23:1997;134-147.
37. Meda L., Cassatella M.A., Szendrei G.I., Otvos L. Jr., Baron P., Villalba M., Ferrari D., Rossi F. Activation of microglial cells by β-amyloid protein and interferon-γ Nature. 374:1995;647-650.
38. Mesulam M.M., Geula C. Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia. Ann. Neurol. 36:1994;722-727.
39. Mrak R.E., Sheng J.G., Griffin W.S. Correlation of astrocytic S100β expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55:1996;372-379.
40. Oda T., Wals P., Osterburg H.H., Johnson S.A., Pasinetti G.M., Morgan T.E., Rozovsky I., Stine W.B., Snyder S.W., Holzman T.F., A Grant G., Finch C.E. Clustern (apoJ) alters the aggregation of amyloid β-peptide (Aβ1-42) and forms slowly sedimenting Aβ complexes that cause oxidative stress. Exp. Neurol. 136:1995;22-31.
41. Pena L.A., Brecher C.W., Marshak D.R. β-amyloid regulates gene expression of glial trophic substance S100β in C6 glioma and primary astrocyte cultures. Mol. Brain Res. 34:1995;118-126.
42. 2. Proc. Natl. Acad. Sci. USA. 96:1999;4668-4673.
43. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13:1993;1676-1687.
44. Pike C.J., Cummings B.J., Monzavi R., Cotman C.W. Beta-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience. 63:1994;517-531.
45. Rogers J.T., Leiter L.M., McPhee J., Cahill C.M., Zhau S.S., Potter H., Nilsson L.N. Translation of the Alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5′-untranslated region sequences. J. Biol. Chem. 274:1999;6421-6431.
46. Sheng J.G., Ito K., Skinner R.D., Mrak R.E., Rovnaghi C.R., Van Eldik L.J., Griffin W.S.T. In vivo and in vitro evidence supporting a role for the inflammatory cytokines interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging. 17:1996;761-766.
47. + astrocytes with neurofibrillary tangle stages. J. Neuropathol. Exp. Neurol. 56:1997;285-290.
48. Sheng J.G., Griffin W.S., Royston M.C., Mrak R.E. Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implication for neuritic plaque formation in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 24:1998;278-283.
49. Singleton A.B., Smith G., Gibson A.M., Woodward R., Perry R.H., Ince P.G., Edwardson J.A., Morris C.M. No association between the K variant of the buryrylcholinesterase gene and pathologically confirmed Alzheimer's disease. Hum. Mol. Gen. 7:1998;937-939.
50. Smith M.A., Richey Harris P.L., Sayre L.M., Beckman J.S., Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17:1997;2653-2657.
51. Styren S.D., Kamboh M.I., DeKosky S.T. Expression of differential immune factors in temporal cortex and cerebellum: the role of α-1-antichymotrypsin, apolipoprotein E, and reactive glia in the progression of Alzheimer's disease. J. Comp. Neurol. 396:1998;511-520.
52. Suo Z., Tan J., Placzek A., Crawford F., Fang C., Mullan M. Alzheimer's β-amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40. Brain Res. 807:1998;110-117.
53. Van Eldik L.J., Griffin W.S.T. S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions. Biochim. Biophys. Acta. 1223:1994;398-403.
54. Wallace M.N., Geddes J.G., Farquhar D.A., Masson M.R. Nitric oxide synthase in reactive astrocytes adjacent to beta-amyloid plaques. Exp. Neurol. 144:1997;266-272.
55. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.